scholarly article | Q13442814 |
P2093 | author name string | Li Zhang | |
Qing Wang | |||
Kan Chen | |||
John Barnard | |||
Gurunathan Murugesan | |||
Maria Febbraio | |||
Arunima Ghosh | |||
Roy L Silverstein | |||
Kandice Marchant | |||
Rita Marie Anselmo | |||
P2860 | cites work | A flexible and accurate genotype imputation method for the next generation of genome-wide association studies | Q21129496 |
CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs | Q24304430 | ||
Structural organization of the gene for human CD36 glycoprotein | Q24305751 | ||
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL | Q24311741 | ||
Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice | Q24551979 | ||
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice | Q24623151 | ||
Molecular basis of human CD36 gene mutations | Q24683083 | ||
Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
Developmental and species-divergent globin switching are driven by BCL11A | Q28506497 | ||
Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain | Q28513542 | ||
CD36 is a receptor for oxidized low density lipoprotein | Q28678362 | ||
Genomic control for association studies | Q29547213 | ||
GenABEL: an R library for genome-wide association analysis | Q29614587 | ||
A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein | Q33379703 | ||
Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies | Q33381588 | ||
CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior | Q33609100 | ||
Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction | Q33653519 | ||
Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults | Q34073895 | ||
Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile | Q34399408 | ||
CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. | Q34415453 | ||
A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling | Q34530236 | ||
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. | Q34592643 | ||
Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells | Q36228153 | ||
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling | Q36384766 | ||
An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction | Q36430809 | ||
Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice | Q36570485 | ||
Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol | Q37127230 | ||
A powerful and flexible multilocus association test for quantitative traits | Q37149380 | ||
Scavenger receptors: role in innate immunity and microbial pathogenesis | Q37456941 | ||
Variability of the CD36 gene in West Africa | Q39020229 | ||
Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma | Q40907616 | ||
Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV. | Q41925073 | ||
Platelet Activation and Aggregation during Cardiopulmonary Bypass | Q42126954 | ||
A whole-genome scan for stroke or myocardial infarction in family blood pressure program families | Q42647524 | ||
A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation | Q42653520 | ||
Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade. | Q42955265 | ||
Insulin sensitivity and lipid metabolism in human CD36 deficiency | Q44291236 | ||
Isolation of the membrane glycoproteins of human blood platelets by lectin affinity chromatography | Q45073654 | ||
CD36 gene promoter polymorphisms are associated with low density lipoprotein-cholesterol in normal twins and after a low-calorie diet in obese subjects | Q46240281 | ||
Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators | Q48028963 | ||
A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. | Q51562671 | ||
Ultrastructural demonstration of CD36 in the alpha-granule membrane of human platelets and megakaryocytes. | Q54039905 | ||
Single-nucleotide Polymorphism of CD36 Locus and Obesity in European Adolescents | Q57605753 | ||
A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians | Q60639709 | ||
Effect of strenuous exercise on platelet activation state and reactivity | Q70489175 | ||
Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation | Q71087721 | ||
Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? | Q73088306 | ||
Platelet GPIbalpha, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men | Q80587956 | ||
Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A | Q80970759 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6355-6366 | |
P577 | publication date | 2011-04-08 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms | |
P478 | volume | 117 |
Q37057946 | A Common CD36 Variant Influences Endothelial Function and Response to Treatment with Phosphodiesterase 5 Inhibition |
Q21144930 | A meta-analysis and genome-wide association study of platelet count and mean platelet volume in african americans |
Q33793807 | Adipose and muscle tissue profile of CD36 transcripts in obese subjects highlights the role of CD36 in fatty acid homeostasis and insulin resistance. |
Q30518002 | Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36. |
Q58576944 | Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin |
Q40523322 | CD36 Provides Host Protection Against Klebsiella pneumoniae Intrapulmonary Infection by Enhancing Lipopolysaccharide Responsiveness and Macrophage Phagocytosis. |
Q27468740 | CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection |
Q35808557 | CD36 genetics and the metabolic complications of obesity |
Q36317868 | CD36 genotype associated with ischemic stroke in Chinese Han. |
Q37348385 | CD36 haplotypes are associated with lipid profile in normal-weight subjects |
Q28478525 | CD9 tetraspanin interacts with CD36 on the surface of macrophages: a possible regulatory influence on uptake of oxidized low density lipoprotein |
Q55334591 | Effect of chemical interaction between oleic acid and L-Arginine on oral perception, as a function of polymorphisms of CD36 and OBPIIa and genetic ability to taste 6-n-propylthiouracil. |
Q27016553 | Emerging roles for platelets as immune and inflammatory cells |
Q30597581 | Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions |
Q92172420 | Functionalization of CD36 cardiovascular disease and expression associated variants by interdisciplinary high throughput analysis |
Q35023208 | Genetic dissection of quantitative trait Loci for hemostasis and thrombosis on mouse chromosomes 11 and 5 using congenic and subcongenic strains |
Q41155155 | Genetic variations of CD36 and low platelet CD36 expression - a risk factor for lipemic plasma donation in Taiwanese apheresis donors |
Q40545995 | Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36. |
Q36035534 | Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts. |
Q30419441 | Imputation of exome sequence variants into population- based samples and blood-cell-trait-associated loci in African Americans: NHLBI GO Exome Sequencing Project. |
Q36351154 | In vitro Incubation of Platelets with oxLDL Does Not Induce Microvesicle Release When Measured by Sensitive Flow Cytometry |
Q41008794 | Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients? |
Q33925367 | Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans |
Q26751393 | Mechanism of fat taste perception: Association with diet and obesity |
Q42133190 | Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy |
Q39919080 | Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade |
Q38271872 | Parkin reinvents itself to regulate fatty acid metabolism by tagging CD36. |
Q42607341 | Platelet CD36 links not only α-granule-derived proteins to thrombus stability but also metabolic and oxidant stress to a prothrombotic phenotype |
Q51089004 | Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions. |
Q58076948 | Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo |
Q47141258 | Polymorphism rs1761667 in the CD36 Gene Is Associated to Changes in Fatty Acid Metabolism and Circulating Endocannabinoid Levels Distinctively in Normal Weight and Obese Subjects |
Q54979354 | Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling. |
Q38127564 | Scavenger receptors in homeostasis and immunity |
Q36824744 | Soluble cluster of differentiation 36 concentrations are not associated with cardiovascular risk factors in middle-aged subjects |
Q34340518 | Sulfo-N-succinimidyl oleate (SSO) inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36 lysine 164: SSO also inhibits oxidized low density lipoprotein uptake by macrophages |
Q89598065 | Taste Changes in Patients with Inflammatory Bowel Disease: Associations with PROP Phenotypes and polymorphisms in the salivary protein, Gustin and CD36 Receptor Genes |
Q35699029 | Teaching an old dog new tricks: potential antiatherothrombotic use for statins |
Q35550211 | The autoimmune concept of atherosclerosis |
Q22337004 | The fatty acid translocase gene CD36 and lingual lipase influence oral sensitivity to fat in obese subjects |
Q36647084 | The origin of circulating CD36 in type 2 diabetes. |
Q42006868 | Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury |
Search more.